Because the binding affinity of PD-L2 and PD-1 is much higher than that of PD1-PD-L1, small molecule targeted drugs can penetrate into tumor microenvironment more effectively, thus enhancing the therapeutic effect. Such as JQ1. Here, CD274 is linked to neoplasm.